SCHEMBL25512557

SCHEMBL25512557

CC(=O)C1CCN(C[C@H]2CC[C@H](C(C)=O)CC2)CC1

nearest known ligand 0.50

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ ACHE P22303 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ DRD2 P14416 2/20 0.41
▸ HTR2A P28223 2/20 0.41
▸ HTR2C P28335 2/20 0.41
▸ HTR2B P41595 2/20 0.41
▸ SIGMAR1 Q99720 2/20 0.41
▸ SMYD3 Q9H7B4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13136048 0.98 SMN1; SMN2 (0.51) SMN1; SMN2ACHEKDM4EALDH1A1PKM
SCHEMBL25498359 0.91 SMN1; SMN2 (0.44) SMN1; SMN2ACHEKDM4EALDH1A1PKM
SCHEMBL25658375 0.91 ACHE (0.52) SMN1; SMN2ACHEKDM4EALDH1A1PKM
SCHEMBL25512217 0.91 ACHE (0.52) SMN1; SMN2ACHEKDM4EALDH1A1PKM
SCHEMBL25695943 0.87 SMN1; SMN2 (0.46) SMN1; SMN2ACHEKDM4EALDH1A1PKM
SCHEMBL25630719 0.86 SMN1; SMN2 (0.43) SMN1; SMN2ACHEKDM4EALDH1A1PKM
SCHEMBL25134096 0.85 SMN1; SMN2 (0.45) SMN1; SMN2ACHEKDM4EALDH1A1PKM
SCHEMBL24003554 0.85 SMN1; SMN2 (0.45) SMN1; SMN2ACHEKDM4EALDH1A1PKM
SCHEMBL27022615 0.79 SMN1; SMN2 (0.46) SMN1; SMN2ACHEKDM4EALDH1A1PKM
SCHEMBL1421748 0.79 SMN1; SMN2 (0.53) SMN1; SMN2ACHEKMT2ADRD2HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023086399-A1 BIFUNCTIONAL DEGRADERS OF HEMATOPOIETIC PROGENITOR KINASE AND THERAPEUTIC USES THEREOF NURIX THERAPEUTICS, INC. (US) 2023-05-19 — — WO disclosed
Send feedback